For media inquiries, please contact us here
Apotex Inc.
150
Signet Drive,
North York,
ON, M9L 1T9
Canada
Email
News
-
March 31, 2016Apobiologix®, a Division of Apotex Inc., today launched Grastofil®, its first subsequent entry biologic (SEB) approved in Canada.
-
March 24, 2016Apotex Inc. announced today that it has launched the first generic version of Merck's Nasonex® nasal spray (mometasone furoate monohydrate) in the United States.
